ストックスクリーナーアプリを入手
3.57
1.42%
0.05
前日終値:
$3.52
開ける：
$3.52
24時間の取引高:
1.21M
Relative Volume:
0.87
時価総額：
$617.03M
収益：
-
当期純損益:
$-54.70M
株価収益率:
-10.82
EPS:
-0.33
ネットキャッシュフロー:
$-51.36M
1週間 パフォーマンス:
+2.59%
1か月 パフォーマンス:
+8.84%
6か月 パフォーマンス:
+28.88%
1年 パフォーマンス:
-15.80%
1日の値動き範囲:
$3.475
$3.57
1週間の範囲:
$3.37
$3.62
52週間の値動き範囲:
$1.89
$4.295
Savara Inc Stock (SVRA) Company Profile
SVRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
3.57 | 608.39M | 0 | -54.70M | -51.36M | -0.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Savara Inc Stock (SVRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-15 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-05-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-12-20 | 開始されました | Wells Fargo | Overweight |
| 2024-11-13 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-02-15 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-11-07 | 開始されました | Guggenheim | Buy |
| 2023-05-16 | アップグレード | Jefferies | Hold → Buy |
| 2023-03-31 | ダウングレード | Jefferies | Buy → Hold |
| 2021-03-16 | 開始されました | Piper Sandler | Overweight |
| 2021-03-15 | 開始されました | Oppenheimer | Outperform |
| 2019-06-13 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-06-13 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-13 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2018-08-13 | 再開されました | ROTH Capital | Neutral |
| 2018-01-03 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-09-27 | 再開されました | ROTH Capital | Buy |
| 2017-09-22 | 開始されました | Jefferies | Buy |
| 2017-09-11 | 開始されました | JMP Securities | Mkt Outperform |
すべてを表示
Savara Inc (SVRA) 最新ニュース
Investors in Savara Inc. (SVRA): Protect Your RightsContact Levi & Korsinsky Before November 7, 2025 - ACCESS Newswire
Class Action Alert: Levi & Korsinsky Reminds Savara Inc. (SVRA) Investors of November 7, 2025 Deadline - ACCESS Newswire
Bragar Eagel & Squire, P.C. Reminds Investors of Tronox, - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors of Tronox, Savara, Quantum, and Fly-E that Class Action Lawsuits Have Been Filed and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Deadline Alert: Savara Inc. (SVRA) Shareholders Who Lost - GlobeNewswire
Can Savara Inc. (YB4P) stock sustain free cash flowTrade Exit Summary & Safe Entry Zone Identification - newser.com
Quantitative breakdown of Savara Inc. recent moveQuarterly Earnings Report & Risk Managed Investment Entry Signals - newser.com
Lost Money on Savara Inc. (SVRA)? Contact Levi & Korsinsky Before November 7, 2025 to Join Class Action - Newsfile
SVRA Investors have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit - PR Newswire
Developing predictive dashboards with Savara Inc. dataPortfolio Profit Report & Fast Gain Swing Alerts - newser.com
How analysts revise price targets for Savara Inc. (YB4P) stockTrade Volume Summary & High Accuracy Investment Signals - newser.com
How to integrate Savara Inc. into portfolio analysis toolsMarket Risk Report & Fast Moving Stock Watchlists - newser.com
November 7, 2025 Deadline Approaching: Join Class Action Against Savara Inc. (SVRA)Contact Levi & Korsinsky - ACCESS Newswire
How Savara Inc. (YB4P) stock trades after earningsMarket Trend Report & Capital Efficiency Focused Strategies - newser.com
The Gross Law Firm Reminds Savara Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025SVRA - PR Newswire
Why Savara Inc. stock could benefit from AI revolution2025 Earnings Impact & Fast Gaining Stock Reports - newser.com
Savara Presents New Data From the Phase 3 IMPALA-2 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the European Respiratory Society (ERS) Congress 2025 - BioSpace
Savara reports positive data from molgramostim trial in rare lung disease - Investing.com
Smart tools for monitoring Savara Inc.’s price actionJuly 2025 Update & Short-Term High Return Ideas - newser.com
Lost Money on Savara Inc. (SVRA)? Contact Levi & Korsinsky to Join Class Action Before November 7, 2025 - ACCESS Newswire
SVRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain OfficersSVRA - PR Newswire
INESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - Newsfile
Investors SueWallSt Over Savara Inc. Stock DropContact Levi & Korsinsky to Join - ACCESS Newswire
Investors in Savara Inc. Should Contact Levi & Korsinsky Before November 7, 2025 to Discuss Your RightsSVRA - FinancialContent
Why Savara Inc. (YB4P) stock appears on watchlists2025 Big Picture & Fast Gaining Stock Reports - newser.com
Levi & Korsinsky Notifies Shareholders of Savara Inc.(SVRA) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar
Securities Lawsuit Alert: Savara Inc. (SVRA) InvestorsContact Levi & Korsinsky Before November 7, 2025 - ACCESS Newswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Savara Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionSVRA - ACCESS Newswire
Savara Inc. (SVRA) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of November 7, 2025 Deadline - ACCESS Newswire
November 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SVRA - GlobeNewswire
Savara Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsSVRA - MarketScreener
Pittsburgh Post-Gazette - FinancialContent
Faruqi & Faruqi Reminds Savara Investors of the Pending - GlobeNewswire
Faruqi & Faruqi Reminds Savara Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025SVRA | FinancialContent - FinancialContent
Lost Money on Savara Inc.(SVRA)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - Morningstar
Class Action Filed Against Savara Inc. (SVRA) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Join Class Action to Recover Losses From Savara Inc. (SVRA)Contact Levi & Korsinsky Before November 7, 2025 - ACCESS Newswire
Savara Inc. Shareholders Who Lost Money in SVRA Should Contact Robbins LLP for Information About Leading the Class Action Lawsuit - Morningstar
About Us - FinancialContent
Pomerantz Law Firm Announces the Filing of a Class Action Agains - GuruFocus
Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain Officers – SVRA - FinancialContent
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on B - GuruFocus
Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - MarketScreener
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - PR Newswire
Rhumbline Advisers Increases Stock Position in Savara Inc. $SVRA - Defense World
ROSEN, A TOP-RANKED LAW FIRM, Encourages Savara Inc. - GlobeNewswire
SVRA NOTICE: Savara Inc. Investors Urged to Contact Kirby McInerney LLP About Securities Fraud Lawsuit - Business Wire
Savara Inc (SVRA) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):